bamlanivimab: Clinical Trials

5 trials of bamlanivimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Unknown 1
Phase 32Completed 2

Follow bamlanivimab: new trials by email Literature Review of bamlanivimab trials Research Report on bamlanivimab

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Bamlanivimab - COVID-19
Phase 2CompletedEli Lilly and Company1092021-02-012021-11-16
Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting
BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB - Covid19
Phase 2UnknownSohail Rao10002020-11-202022-03-29
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
Bamlanivimab, Etesevimab, Placebo - COVID-19
Phase 2CompletedEli Lilly and Company17552020-10-292022-07-01
ACTIV-2: A Study for Outpatients With COVID-19
bamlanivimab 7000mg, BRII-196+BRII-198, AZD7442 (IV) - Coronavirus, Covid19
Phase 2 / Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)40442020-08-192024-08-02
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness
LY3819253, LY3832479, LY3853113 - COVID-19
Phase 2 / Phase 3CompletedEli Lilly and Company33072020-06-172024-04-11

Conditions studied

COVID-19 (5)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Nidovirales Infections (1)  ·  RNA Virus Infections (1)  ·  Severe Acute Respiratory Syndrome (1)  ·  Virus Diseases (1)

Sponsors

Eli Lilly and Company (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Sohail Rao (1)

Countries

United States (5)  ·  Argentina (2)  ·  Puerto Rico (2)  ·  Brazil (1)  ·  Canada (1)  ·  Guatemala (1)  ·  Mexico (1)  ·  Philippines (1)  ·  South Africa (1)

Top investigators

David Smith, MD, MAS (1)  ·  Sohail Rao, MD (1)

Results publications

PMID 34473343, PMID 35713300, PMID 34374951, PMID 33113295, PMID 33475701, PMID 34260849, PMID 34346827, PMID 34718468, PMID 34981077, PMID 35493124, PMID 35793677, PMID 35797235, PMID 35995785, PMID 36210483, PMID 36289399, PMID 36301549, PMID 36378539, PMID 36467293, PMID 36661240, PMID 36802755, PMID 37068272, PMID 37099295, PMID 37279602, PMID 37329415, PMID 37650230, PMID 37650232, PMID 37650233, PMID 37650236, PMID 37855026, PMID 38291279, PMID 39018444, PMID 39028902, PMID 39230829, PMID 42148571